Related Experiment Video
Updated: Sep 22, 2026

Murine Colitis Modeling using Dextran Sulfate Sodium (DSS)
Published on: January 19, 2010
A low-molecular-weight carbohydrate fraction from Salvia miltiorrhiza mitigates DSS-induced colitis
Hao-Cheng Zheng1, Xiang-Yu Huang2, Cong Gai1
1Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 102488, China.
Abstract:
Plant polysaccharides are functional carbohydrates with diverse structures and close interactions with the gut microbiota. Here, a low-molecular-weight neutral carbohydrate fraction, SMP-1, was isolated from Salvia miltiorrhiza and characterized for molecular weight, monosaccharide composition, linkage features, and selected NMR correlations. SMP-1 showed an apparent molecular weight of approximately 3.3 kDa. Complementary monosaccharide analyses indicated Gal, Glc, and Ara as the main detected sugars, with trace Fru. Methylation analysis mainly described the Galp/Glcp-rich portion and suggested abundant terminal Galp, 6-linked Galp, and 6-linked Glcp residues, whereas Fru-derived linkages were not resolved under the present methylation-GC-MS conditions. NMR analysis supported major Glcp/Galp spin systems and Fruf-containing residues, but a complete repeating-unit structure was not assigned. In a dextran sulfate sodium-induced colitis model, oral SMP-1 alleviated body weight loss, disease activity, colon shortening, and mucosal injury; restored mucus secretion and tight junction integrity; reduced pro-inflammatory cytokines; and suppressed TLR4/NF-κB signaling. SMP-1 also partially restored microbial diversity and reshaped DSS-disrupted gut microbial composition, while antibiotic-mediated microbiota depletion weakened its protective effects. These findings suggest that SMP-1 improves colitis-associated intestinal dysfunction through regulation of gut microbiota, epithelial barrier integrity, and inflammatory responses.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...

